FDA vouched Immunotherapy is really the future of Cancer Treatment

New Delhi: The realization is slowly but surely dawning on oncology world that reinforced immune system might be the best bet in fight against cancer in times to come. US’s FDA (Food and Drug Administration) too has clearly vouched this in the preceding year.

In 2016 ESMO (European Society for Oncology) Congress in Canada, a near consensus emerged that immunotherapy is going to be the future of Cancer treatment. Close on the heels, FDA buttressed this thinking.

Dr R.K.Choudhary, Senior Medical Oncologist, Metro Hospital and Cancer Institute, who participated in that very crucial ESMO Congress, revealed this. Talking to Medicare News on the occasion of World Cancer Day, Dr Choudhary said, ‘Immunotherapy medicines constituted the lion’s share of medicines that FDA approved in 2017. This surely indicates the future of cancer treatment. Immunotherapy soon may become the first line of treatment.’

Immunotherapy has been in India for quite a while but, not long ago, it was dubbed as quackery. But now the evidences have piled up in favour of immunotherapy. A new version of immunotherapy by dendritic cells, originating from Germany, is changing the game of fight against cancer. A single vaccine created from patient’s own blood has been found very effective in remission of cancer. It works by boosting immunity which takes on cancer cells and kills them.

Dr Choudhary further said, ‘Increasing cases of cancers should be a matter great concern in the country. In last 2-3 years, the cancer has become a household word. The theme of this year’s World Cancer Day theme ‘We Can, I can, Early detections save lives’ embodies the key to the solution of this catastrophe.’

Dr Choudhary added, ‘Chemotherapy has come a long way from its earlier stage when it was considered worse than the disease. Chemotherapy is increasingly becoming refined and side effects have greatly eased.’

In the mean time, India is all set to enter the exclusive League of Nations which posses the expensive facility of proton therapy. This year may propel India to become the first country in South East Asia to have this facility. Apollo has almost installed this facility in its Chennai hospital. Proton therapy is being flaunted as the ultimate in cancer treatment.

To mark the day, Metro Hospital and Cancer Institute conducted 4 day free cancer screening.  This institute is the oldest cancer institute in Delhi. This was the first cobalt Centre in Delhi. In a decade oncology here, the institute can claim a number of cancer survivors.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Senores Pharma to Buy Two Teva ANDAs

    Senores Pharma to Buy Two Teva ANDAs

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lilly launches Mounjaro KwikPen in India

    Lilly launches Mounjaro KwikPen in India